
384: Live from the JP Morgan conference, a sit-down with Novo Nordisk's CEO and VC Bob Nelsen
The Readout Loud
00:00
Regulatory changes: FDA, CMS and urgency
Bob critiques the FDA, urges faster regulatory approaches, and calls for administrative fixes.
Play episode from 37:36
Transcript


